Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

Scolnik M, Singh G

Open Access Rheumatology: Research and Reviews 2011, 3:53-62

Published Date: 4 August 2011